BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 29187487)

  • 1. Stereotactic Body Radiation Therapy in Primary and Metastatic Liver Disease.
    Caivano D; Valeriani M; Russo I; Bonome P; DE Matteis S; Minniti G; Osti MF
    Anticancer Res; 2017 Dec; 37(12):7005-7010. PubMed ID: 29187487
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stereotactic Body Radiation Therapy for Liver Lesions. A Single-institution Experience.
    Caivano D; Bracci S; Russo I; Montalto A; Armosini V; De Sanctis V; Valeriani M; Minniti G; Enrici RM; Osti MF
    Anticancer Res; 2015 Jul; 35(7):4171-5. PubMed ID: 26124374
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment outcomes of breast cancer liver metastasis treated with stereotactic body radiotherapy.
    Onal C; Guler OC; Yildirim BA
    Breast; 2018 Dec; 42():150-156. PubMed ID: 30296648
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Re-irradiation stereotactic body radiotherapy for spinal metastases: a multi-institutional outcome analysis.
    Hashmi A; Guckenberger M; Kersh R; Gerszten PC; Mantel F; Grills IS; Flickinger JC; Shin JH; Fahim DK; Winey B; Oh K; John Cho BC; Létourneau D; Sheehan J; Sahgal A
    J Neurosurg Spine; 2016 Nov; 25(5):646-653. PubMed ID: 27341054
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stereotactic Body Radiotherapy (SBRT) for Spinal Metastases: Who Will Benefit the Most from SBRT?
    Park HJ; Kim HJ; Won JH; Lee SC; Chang AR
    Technol Cancer Res Treat; 2015 Apr; 14(2):159-67. PubMed ID: 24502552
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The challenge of inoperable hepatocellular carcinoma (HCC): results of a single-institutional experience on stereotactic body radiation therapy (SBRT).
    Scorsetti M; Comito T; Cozzi L; Clerici E; Tozzi A; Franzese C; Navarria P; Fogliata A; Tomatis S; D'Agostino G; Iftode C; Mancosu P; Ceriani R; Torzilli G
    J Cancer Res Clin Oncol; 2015 Jul; 141(7):1301-9. PubMed ID: 25644863
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dose-escalation study of single-fraction stereotactic body radiotherapy for liver malignancies.
    Goodman KA; Wiegner EA; Maturen KE; Zhang Z; Mo Q; Yang G; Gibbs IC; Fisher GA; Koong AC
    Int J Radiat Oncol Biol Phys; 2010 Oct; 78(2):486-93. PubMed ID: 20350791
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stereotactic body radiation therapy: A promising chance for oligometastatic breast cancer.
    Scorsetti M; Franceschini D; De Rose F; Comito T; Villa E; Iftode C; Navarria P; D'Agostino GR; Masci G; Torrisi R; Testori A; Tinterri C; Santoro A
    Breast; 2016 Apr; 26():11-7. PubMed ID: 27017237
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stereotactic Body Radiation Therapy for Liver Tumors: Current Status and Perspectives.
    Doi H; Beppu N; Kitajima K; Kuribayashi K
    Anticancer Res; 2018 Feb; 38(2):591-599. PubMed ID: 29374681
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stereotactic body radiotherapy (SBRT) with or without surgery for primary and metastatic liver tumors.
    Kirichenko A; Gayou O; Parda D; Kudithipudi V; Tom K; Khan A; Abrams P; Szramowski M; Oliva J; Monga D; Raj M; Thai N
    HPB (Oxford); 2016 Jan; 18(1):88-97. PubMed ID: 26776856
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical outcomes and dosimetric considerations using stereotactic body radiotherapy for abdominopelvic tumors.
    Barney BM; Olivier KR; Macdonald OK; Fong de Los Santos LE; Miller RC; Haddock MG
    Am J Clin Oncol; 2012 Dec; 35(6):537-42. PubMed ID: 21659830
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Medically inoperable peripheral lung cancer treated with stereotactic body radiation therapy.
    Kelley KD; Benninghoff DL; Stein JS; Li JZ; Byrnes RT; Potters L; Knisely JP; Zinkin HD
    Radiat Oncol; 2015 May; 10():120. PubMed ID: 26018408
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stereotactic body radiation therapy for abdominal and pelvic oligometastases: Dosimetric targets for safe and effective local control.
    Rwigema JM; King C; Wang PC; Kamrava M; Kupelian P; Steinberg ML; Lee P
    Pract Radiat Oncol; 2015; 5(3):e183-e191. PubMed ID: 25413386
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term safety and efficacy of stereotactic body radiation therapy for hepatic oligometastases.
    Goodman BD; Mannina EM; Althouse SK; Maluccio MA; Cárdenes HR
    Pract Radiat Oncol; 2016; 6(2):86-95. PubMed ID: 26725957
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multiple Site SBRT in Pediatric, Adolescent, and Young Adult Patients With Recurrent and/or Metastatic Sarcoma.
    Parsai S; Sedor G; Smile TD; Scott J; Ochocki A; Vassil N; Zahler S; Angelov L; Chao ST; Qi P; Anderson P; Murphy ES
    Am J Clin Oncol; 2021 Mar; 44(3):126-130. PubMed ID: 33405479
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stereotactic body radiotherapy for metastatic spinal sarcoma: a detailed patterns-of-failure study.
    Leeman JE; Bilsky M; Laufer I; Folkert MR; Taunk NK; Osborne JR; Arevalo-Perez J; Zatcky J; Alektiar KM; Yamada Y; Spratt DE
    J Neurosurg Spine; 2016 Jul; 25(1):52-8. PubMed ID: 26943256
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stereotactic body radiation therapy (SBRT) for definitive treatment and as a bridge to liver transplantation in early stage inoperable Hepatocellular carcinoma.
    Moore A; Cohen-Naftaly M; Tobar A; Kundel Y; Benjaminov O; Braun M; Issachar A; Mor E; Sarfaty M; Bragilovski D; Hur RB; Gordon N; Stemmer SM; Allen AM
    Radiat Oncol; 2017 Oct; 12(1):163. PubMed ID: 29052532
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment variables related to liver toxicity in patients with hepatocellular carcinoma, Child-Pugh class A and B enrolled in a phase 1-2 trial of stereotactic body radiation therapy.
    Lasley FD; Mannina EM; Johnson CS; Perkins SM; Althouse S; Maluccio M; Kwo P; Cárdenes H
    Pract Radiat Oncol; 2015; 5(5):e443-e449. PubMed ID: 25899219
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multi-institutional phase I/II trial of stereotactic body radiation therapy for liver metastases.
    Rusthoven KE; Kavanagh BD; Cardenes H; Stieber VW; Burri SH; Feigenberg SJ; Chidel MA; Pugh TJ; Franklin W; Kane M; Gaspar LE; Schefter TE
    J Clin Oncol; 2009 Apr; 27(10):1572-8. PubMed ID: 19255321
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potential role for LINAC-based stereotactic radiosurgery for the treatment of 5 or more radioresistant melanoma brain metastases.
    Frakes JM; Figura NB; Ahmed KA; Juan TH; Patel N; Latifi K; Sarangkasiri S; Strom TJ; Chinnaiyan P; Rao NG; Etame AB
    J Neurosurg; 2015 Nov; 123(5):1261-7. PubMed ID: 26140482
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.